• 1
    Warren JR. Unidentified curved bacilli on gastric epithelium in active chronic gastritis. Lancet 1983; I: 12731273.
  • 2
    Parsonnet J. Helicobacter pylori. Infect Dis Clin North Am 1998; 12: 18597.
  • 3
    Blaser MJ. The role of Helicobacter pylori in gastritis and its progression to peptic ulcer disease. Aliment Pharmacol Ther 1995; 9: 2730.
  • 4
    Hopkins RJ, Girardi LS, Turney EA. Relationship between Helicobacter pylori eradication and reduced duodenal and gastric ulcer recurrence: a review. Gastroenterology 1996; 110: 124452.
  • 5
    Van Der Hulst RWM, Rauws EAJ, Köycü B, et al. Prevention of ulcer recurrence after eradication of Helicobacter pylori: a prospective long-term follow-up study. Gastroenterology 1997; 113: 10826.
  • 6
    Lind T, Veldhuyzen van Zanten S, Unge P, et al. Eradication of Helicobacter pylori using one-week triple therapies combining omeprazole with two antimicrobials: the MACH I Study. Helicobacter 1996; 1: 13844.
  • 7
    The European Helicobacter pylori Study Group. Current European concepts in the management of Helicobacter pylori infection. The Maastricht Consensus Report. Gut 1997; 41: 813.
  • 8
    Lam SK & Talley NJ. Report of the 1997 Asia Pacific Consensus Conference on the management of Helicobacter pylori infection. J Gastroenterol Hepatol 1998; 13: 112.
  • 9
    Hurenkamp GJB, Van Der Ende A, Grundmeijer HGLM, Tytgat GNJ, Van Der Hulst RWM. Equally high efficacy of 4, 7 and 10-day triple therapies to eradicate Helicobacter pylori infection in patients with ulcer disease. Aliment Pharmacol Ther 2000; 14: 106570.DOI: 10.1046/j.1365-2036.2000.00800.x
  • 10
    Frevel M, Daake H, Janisch HD, et al. Eradication of Helicobacter pylori with pantoprazole and two antibiotics: a comparison of two short-term regimens. Aliment Pharmacol Ther 2000; 14: 11517.DOI: 10.1046/j.1365-2036.2000.00827.x
  • 11
    Houben MHMG, Hensen EF, Rauws EAJ, et al. Randomized trial of omeprazole and clarithromycin combined with either metronidazole or amoxycillin in patients with metronidazole-resistant or -susceptible Helicobacter pylori strains. Aliment Pharmacol Ther 1999; 13: 8839.
  • 12
    Wurzer H, Rodrigo L, Stamler D, et al. Short-course therapy with amoxycillin-clarithromycin triple therapy for 10 days (ACT-10) eradicates Helicobacter pylori and heals duodenal ulcer. Aliment Pharmacol Ther 1997; 11: 94352.
  • 13
    Xiao SD, Liu WZ, Hu PJ, et al. A multicentre study on eradication of Helicobacter pylori using four 1-week triple therapies in China. Aliment Pharmacol Ther 2001; 15: 816.
  • 14
    Gisbert JP, Gonzalez L, Calvet X, et al. Proton pump inhibitor, clarithromycin and either amoxycillin or nitroimidazole: a meta-analysis of eradication of Helicobacter pylori. Aliment Pharmacol Ther 2000; 14: 131928.DOI: 10.1046/j.1365-2036.2000.00844.x
  • 15
    Graham DY. Antibiotic resistance in Helicobacter pylori: implications for therapy. Gastroenterology 1998; 115: 12727.
  • 16
    Mégraud F & Doermann HP. Clinical relevance of resistant strains of Helicobacter pylori: a review of current data. Gut 1998; 43(Suppl. 1): S615.
  • 17
    Houben MHMG, Van De Beek D, Hensen EF, De Craen AJM, Rauws EAJ, Tytgat GNJ. A systematic review of Helicobacter pylori eradication therapy—the impact of antimicrobial resistance on eradication rates. Aliment Pharmacol Ther 1999; 13: 104755.
  • 18
    Mégraud F. Resistance of Helicobacter pylori to antibiotics. Aliment Pharmacol Ther 1997; 11(Suppl. 1): 4353.
  • 19
    Glupczynski Y. Antimicrobial resistance in Helicobacter pylori: a global overview. Acta Gastroenterol Belg 1998; 61: 35766.
  • 20
    Van Der Wouden EJ, Thijs JC, Van Zwet AA, Kleibeuker JH. Review article: nitroimidazole resistance in Helicobacter pylori. Aliment Pharmacol Ther 2000; 14: 714.DOI: 10.1046/j.1365-2036.2000.00675.x
  • 21
    Dore MP, Piana A, Carta M, et al. Amoxycillin resistance is one reason for failure of amoxycillin–omeprazole treatment of Helicobacter pylori infection. Aliment Pharmacol Ther 1998; 12: 6359.
  • 22
    Dore MP, Osato MS, Realdi G, Mura I, Graham DY, Sepulveda AR. Amoxycillin tolerance in Helicobacter pylori. J Antimicrob Chemother 1999; 43: 4754.
  • 23
    Mendonca S, Ecclissato C, Sartori MS, et al. Prevalence of Helicobacter pylori resistance to metronidazole, clarithromycin, amoxicillin, tetracycline, and furazolidone in Brazil. Helicobacter 2000; 5: 7983.DOI: 10.1046/j.1523-5378.2000.00011.x
  • 24
    Yang JC, Wang TH, Wang HJ, Kuo CH, Wang JT, Wang WC. Genetic analysis of the cytotoxin-associated gene and the vacuolating toxin gene in Helicobacter pylori strains isolated from Taiwanese patients. Am J Gastroenterol 1997; 92: 131621.
  • 25
    Kuo CH, Poon SK, Su YC, Su R, Chang CS, Wang WC. Heterogeneous Helicobacter pylori isolates from H. pylori-infected couples in Taiwan. J Infect Dis 1999; 180: 20648.
  • 26
    Bazzoli F, Pozzato P, Zagari M, et al. Efficacy of lansoprazole in eradicating Helicobacter pylori: a meta-analysis. Helicobacter 1998; 3: 195201.
  • 27
    Wong BCY, Wong WM, Wang WH, et al. One-week ranitidine bismuth citrate-based triple therapy for the eradication of Helicobacter pylori in Hong Kong with high prevalence of metronidazole resistance. Aliment Pharmacol Ther 2001; 15: 4039.
  • 28
    Van Der Wouden EJ, Thijs JC, Van Zwet AA, Sluiter WJ, Kleibeuker JH. The influence of in vitro nitroimidazole resistance on the efficacy of nitroimidazole-containing anti-Helicobacter pylori regimens: a meta-analysis. Am J Gastroenterol 1999; 94: 17519.
  • 29
    Tankovic J, Lamarque D, Lascols C, Soussy CJ, Delchier JC. Impact of Helicobacter pylori resistance to clarithromycin on the efficacy of the omeprazole–amoxicillin–clarithromycin therapy. Aliment Pharmacol Ther 2001; 15: 70713.
  • 30
    Vakil N, Hahn B, McSorley D. Clarithromycin-resistant Helicobacter pylori in patients with duodenal ulcer in the United States. Am J Gastroenterol 1998; 93: 14325.
    Direct Link:
  • 31
    Osato MS, Reddy R, Reddy SG, Penland RL, Malaty HM, Graham DY. Pattern of primary resistance of Helicobacter pylori to metronidazole or clarithromycin in the United States. Arch Intern Med 2001; 161: 121720.
  • 32
    Cabrita J, Oleastro M, Matos R, et al. Features and trends in Helicobacter pylori antibiotic resistance in Lisbon area, Portugal (1990–99). J Antimicrob Chemother 2000; 46: 102931.
  • 33
    Mollison LC, Stingemore N, Wake RA, Cullen DJ, McGechie DB. Antibiotic resistance in Helicobacter pylori. Med J Aust 2000; 173: 5213.
  • 34
    Kato M, Yamaoka Y, Kim JJ, et al. Regional differences in metronidazole resistance and increasing clarithromycin resistance among Helicobacter pylori isolates from Japan. Antimicrob Agents Chemother 2000; 44: 22146.
  • 35
    Wang WH, Wong BCY, Mukhopadhyay AK, et al. High prevalence of Helicobacter pylori infection with dual resistance to metronidazole and clarithromycin in Hong Kong. Aliment Pharmacol Ther 2000; 14: 90110.DOI: 10.1046/j.1365-2036.2000.00795.x
  • 36
    Ducóns JA, Santolaria S, Guirao R, Ferrero M, Montoro M, Gomollón F. Impact of clarithromycin resistance on the effectiveness of a regimen for Helicobacter pylori: a prospective study of 1-week lansoprazole, amoxycillin and clarithromycin in active peptic ulcer. Aliment Pharmacol Ther 1999; 13: 77580.DOI: 10.1046/j.1365-2036.1999.00549.x
  • 37
    Laine L, Suchower L, Frantz J, Connors A, Neil G. Low rate of emergence of clarithromycin-resistant Helicobacter pylori with amoxycillin co-therapy. Aliment Pharmacol Ther 1998; 12: 88792.
  • 38
    Katelaris PH, Adamthwaite D, Midolo P, Yeomans ND, Davidson G, Lambert J. Randomized trial of omeprazole and metronidazole with amoxycillin or clarithromycin for Helicobacter pylori eradication, in a region of high primary metronidazole resistance: the HERO study. Aliment Pharmacol Ther 2000; 14: 7518.DOI: 10.1046/j.1365-2036.2000.00776.x